Akston Biosciences

United States
Osceola, Iowa, United States

Company profile

Akston Biosciences company profile

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. It was founded in 2011 and headquartered in Beverly, Massachusetts.

Business identity

Contact email
[email protected]
Phone number
978-969-3381
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
14
Total equity funding
$42.4M
Last funding
Series H / 2025-04-30
Last equity funding
Series H
Investors
5
Lead investors
1
Founders
1
Articles
36

Founders and investors

Founders

Todd C. Zion

Lead investors

National Institute of Diabetes and Digestive and Kidney Diseases

Investors

Angel Healthcare InvestorsCherrystone Angel GroupEQx FundNational Institute of Diabetes and Digestive and Kidney DiseasesPropel(X)